Cipla, South Africa’s third-largest pharmaceutical manufacturer, in collaboration with Teva Pharmaceutical Industries Ltd, has announced the launch of the country’s first biosimilar for the oncology and haematology markets.
Continue reading…
A first for South Africa:- Biosimilar oncology drug authorised for use
Posted on Leave a comment
